Atezolizumab Plus Standard Care Improves Survival in Advanced Cervical Cancer

FRIDAY, Jan. 5, 2024 -- For patients with metastatic, persistent, or recurrent cervical cancer, adding atezolizumab to a standard bevacizumab plus platinum regimen significantly improves progression-free and overall survival, according to a study...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news